Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 7 | $2,778,819 |
| Sells | 11 | $5,386,399 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 21 Oct 2024 20:22 | ALDX | Aldeyra Therapeutics Inc | MILLER-RICH NANCY | Director | 03 May 2021 | Purchase | 413 | 12.81 | 5,291 | D |
| 21 Oct 2024 20:22 | ALDX | Aldeyra Therapeutics Inc | MILLER-RICH NANCY | Director | 12 Apr 2023 | Purchase | 509 | 10.13 | 5,156 | D |
| 14 Aug 2024 16:24 | ALDX | Aldeyra Therapeutics Inc | MACHATHA STEPHEN | Chief Development Officer | 12 Aug 2024 | Sale | 16,041 | 4.7363 | 75,975 | D |
| 14 Aug 2024 16:24 | ALDX | Aldeyra Therapeutics Inc | GREENBERG BRUCE | See Remarks | 12 Aug 2024 | Sale | 10,834 | 4.7363 | 51,313 | D |
| 17 Apr 2024 16:12 | ALDX | Aldeyra Therapeutics Inc | MACHATHA STEPHEN | Chief Development Officer | 12 Mar 2024 | Sale A | 11,537 | 3.164 | 36,503 | D |
| 17 Apr 2024 16:10 | ALDX | Aldeyra Therapeutics Inc | GREENBERG BRUCE | See Remarks | 11 Mar 2024 | Sale A | 13,201 | 3.4064 | 44,968 | D |
| 08 Apr 2024 17:32 | ALDX | Aldeyra Therapeutics Inc | PERCEPTIVE ADVISORS LLC | 10% | 05 Apr 2024 | Purchase | 37,712 | 4.74 | 178,755 | I |
| 08 Apr 2024 17:32 | ALDX | Aldeyra Therapeutics Inc | PERCEPTIVE ADVISORS LLC | 10% | 04 Apr 2024 | Purchase | 140,281 | 4.67 | 655,112 | I |
| 03 Apr 2024 17:22 | ALDX | Aldeyra Therapeutics Inc | PERCEPTIVE ADVISORS LLC | 10% | 03 Apr 2024 | Purchase | 309,847 | 4.09 | 1,267,274 | I |
| 03 Apr 2024 17:22 | ALDX | Aldeyra Therapeutics Inc | PERCEPTIVE ADVISORS LLC | 10% | 02 Apr 2024 | Purchase | 186,051 | 3.44 | 640,015 | I |
| 03 Apr 2024 17:22 | ALDX | Aldeyra Therapeutics Inc | PERCEPTIVE ADVISORS LLC | 10% | 01 Apr 2024 | Purchase | 8,374 | 3.25 | 27,216 | I |
| 12 Mar 2024 20:07 | ALDX | Aldeyra Therapeutics Inc | GREENBERG BRUCE | See Remarks | 11 Mar 2024 | Sale | 13,201 | 3.4064 | 44,968 | D |
| 12 Mar 2024 20:04 | ALDX | Aldeyra Therapeutics Inc | MACHATHA STEPHEN | Chief Development Officer | 12 Mar 2024 | Sale | 11,537 | 3.164 | 36,503 | D |
| 12 Mar 2024 20:04 | ALDX | Aldeyra Therapeutics Inc | MACHATHA STEPHEN | Chief Development Officer | 11 Mar 2024 | Sale | 18,231 | 3.4064 | 62,102 | D |
| 12 Mar 2024 20:01 | ALDX | Aldeyra Therapeutics Inc | BRADY TODD C | President and CEO | 12 Mar 2024 | Sale | 85,324 | 3.05 | 260,238 | D |
| 12 Mar 2024 20:01 | ALDX | Aldeyra Therapeutics Inc | BRADY TODD C | President and CEO | 11 Mar 2024 | Sale | 97,914 | 3.2735 | 320,521 | D |
| 18 Oct 2023 17:15 | ALDX | Aldeyra Therapeutics Inc | PERCEPTIVE ADVISORS LLC | 10% | 18 Oct 2023 | Sale | 306,499 | 1.74 | 533,308 | I |
| 18 Oct 2023 17:15 | ALDX | Aldeyra Therapeutics Inc | PERCEPTIVE ADVISORS LLC | 10% | 16 Oct 2023 | Sale | 2,450,000 | 1.6 | 3,920,000 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)